Construction of a New Dual-Responsive Nano-Drug Delivery System for Matrix Metalloproteinases and Adenosine Triphosphate in Ovarian Cancer Using Nanomicelles
Doxorubicin Hydrochloride
Viability assay
DOI:
10.1166/jbn.2022.3303
Publication Date:
2022-06-18T04:42:13Z
AUTHORS (5)
ABSTRACT
In this manuscript we constructed a dual-responsive nano-drug delivery system for matrix metalloproteinases and ATP in ovarian cancer microenvironment. The nanomicelle PCL-DNA/DOX-Peptide-PEG was prepared by intercalating doxorubicin hydrochloride between C G base pairs of DNA double helix structure. Another ATP-responsive PCL-DNA/DOX-PEG prepared. Then analyzed the characterization nanomicelles (particle size, potential, surface morphology, etc.) drug loading binding release behavior. addition, effect on viability mouse epithelial tumor cell ID-8 detected CCK-8 method. assay that different concentrations carrier had no difference proliferation cells, survival rate cells DOX preparations statistically significant same results were observed cytotoxicity comparison. Confocal microscopy showed drug-loaded micelle group concentrated nucleus, while free cytoplasm. took up micelles faster. semi-quantitative analysis uptake with treatments extremely statistical differences. conclusion, self-assembled is novel anti-tumor agent, expected to have good tissue penetration ability low toxicity.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (29)
CITATIONS (4)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....